Declaration of competing financial interests
From the following article:
Targeting the mitogen-activated protein kinase cascade to treat cancer
Judith S. Sebolt-Leopold & Roman Herrera
Nature Reviews Cancer 4, 937-947 (December 2004)
doi:10.1038/nrc1503
Declaration: Both authors are employed by Pfizer Global Research and Development. Pfizer is widely known to have an active interest in the clinial development of MEK inhibitors — a subject that is included in this review.
